Results 291 to 300 of about 390,247 (379)

Human germ cell differentiation from fetal- and adult-derived induced pluripotent stem cells [PDF]

open access: green, 2010
Sarita Panula   +10 more
openalex   +1 more source

Autoantibody pathogenicity in a multifocal motor neuropathy induced pluripotent stem cell–derived model

open access: yesAnnals of Neurology, 2016
O. Harschnitz   +11 more
semanticscholar   +1 more source

Pharmacological Inhibition of β Myosin II Disrupts Sarcomere Assembly in Human iPSC‐Derived Cardiac Myocytes

open access: yesCytoskeleton, EarlyView.
ABSTRACT Sarcomeres are the fundamental contractile units of striated muscle. The functional roles of the cardiac‐specific myosin heavy chains, MYH6 (α myosin II) and MYH7 (β myosin II) during sarcomere assembly remain controversial. To address this, we utilized a selective MYH7 inhibitor, mavacamten, in combination with siRNA‐mediated knockdown of ...
James B. Hayes, Dylan T. Burnette
wiley   +1 more source

Human induced pluripotent stem cell-derived myotubes to model inclusion body myositis. [PDF]

open access: yesActa Neuropathol Commun
Cantó-Santos J   +19 more
europepmc   +1 more source

Generation of mouse-induced pluripotent stem cells with plasmid vectors [PDF]

open access: green, 2010
Keisuke Okita   +3 more
openalex   +1 more source

NRF2 Orchestrates the Metabolic Shift during Induced Pluripotent Stem Cell Reprogramming

open access: yesCell Reports, 2016
Kate E. Hawkins   +11 more
semanticscholar   +1 more source

Update on preclinical models of cancer therapy‐related cardiac dysfunction: Challenges and perspectives. A scientific statement of the Heart Failure Association (HFA) of the ESC, the ESC Council of Cardio‐Oncology, and the ESC Working Group on Cellular Biology of the Heart

open access: yesEuropean Journal of Heart Failure, EarlyView.
New anticancer therapies with potential cardiovascular side effects are continuously being introduced into clinical practice, with new and often unexpected toxicities becoming apparent only after clinical introduction. These unknown toxicities should be identified and understood beforehand to better prepare patients and physicians, enabling the ...
Alessandra Ghigo   +22 more
wiley   +1 more source

Mitochondrial targets in ischaemic heart disease and heart failure, and their potential for a more efficient clinical translation. A scientific statement of the ESC Working Group on Cellular Biology of the Heart and the ESC Working Group on Myocardial Function

open access: yesEuropean Journal of Heart Failure, EarlyView.
Improving clinical translation of mitoprotective therapies. 31P MRI, phosphorus‐31 magnetic resonance imaging; hiPSC‐CM, human‐induced pluripotent stem cell‐derived cardiomyocyte; IHD, ischaemic heart disease. Abstract Acute myocardial infarction (MI) remains a major cause of death and disability worldwide.
Melanie Paillard   +29 more
wiley   +1 more source

Home - About - Disclaimer - Privacy